PMID- 10023327
OWN - NLM
STAT- MEDLINE
DCOM- 19990225
LR  - 20220310
IS  - 0959-8049 (Print)
IS  - 0959-8049 (Linking)
VI  - 34
IP  - 12
DP  - 1998 Nov
TI  - MSH2 codon 322 Gly to Asp seems not to confer an increased risk for colorectal
      cancer susceptibility.
PG  - 1981
FAU - Liu, T
AU  - Liu T
FAU - Stathopoulos, P
AU  - Stathopoulos P
FAU - Lindblom, P
AU  - Lindblom P
FAU - Rubio, C
AU  - Rubio C
FAU - Wasteson Arver, B
AU  - Wasteson Arver B
FAU - Iselius, L
AU  - Iselius L
FAU - Holmberg, E
AU  - Holmberg E
FAU - Gronberg, H
AU  - Gronberg H
FAU - Lindblom, A
AU  - Lindblom A
LA  - eng
PT  - Letter
PT  - Research Support, Non-U.S. Gov't
PL  - England
TA  - Eur J Cancer
JT  - European journal of cancer (Oxford, England : 1990)
JID - 9005373
RN  - 0 (Codon)
RN  - 0 (DNA-Binding Proteins)
RN  - 0 (Proto-Oncogene Proteins)
RN  - EC 3.6.1.3 (MSH2 protein, human)
RN  - EC 3.6.1.3 (MutS Homolog 2 Protein)
SB  - IM
MH  - Codon
MH  - Colorectal Neoplasms/*genetics
MH  - *DNA-Binding Proteins
MH  - *Genetic Predisposition to Disease
MH  - Humans
MH  - MutS Homolog 2 Protein
MH  - Mutation/genetics
MH  - Proto-Oncogene Proteins/*genetics
MH  - Risk Factors
EDAT- 1999/02/19 00:00
MHDA- 1999/02/19 00:01
CRDT- 1999/02/19 00:00
PHST- 1999/02/19 00:00 [pubmed]
PHST- 1999/02/19 00:01 [medline]
PHST- 1999/02/19 00:00 [entrez]
AID - S0959804998002172 [pii]
AID - 10.1016/s0959-8049(98)00217-2 [doi]
PST - ppublish
SO  - Eur J Cancer. 1998 Nov;34(12):1981. doi: 10.1016/s0959-8049(98)00217-2.